INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Waldencast plc - WALD

GlobeNewswire Inc. • Dec 30, 2025 3:52pm (New York) •By Pomerantz Llp

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Waldencast plc - WALD

Pomerantz LLP is investigating potential securities fraud claims against Waldencast plc following the company's November 24, 2025 announcement of significantly reduced financial guidance and substantial impairment charges. Waldencast downgraded its 2025 net revenue growth expectations from mid-teens to flat compared to 2024, and reduced adjusted EBITDA margin guidance from mid-to-high teens to high single digits. The company reported a $185.2 million net loss for H1 2025, including $132.1 million in impairment charges on its Obagi Medical brand and $20 million on Milk Makeup. The stock fell 6.49% on the announcement.

← Back to news Read Original Article

Insights

WALD negative

Company faces securities fraud investigation, issued significant downward guidance revisions (mid-teens growth to flat revenue, mid-to-high teens to high single digits EBITDA margin), reported substantial impairment charges totaling $152.1 million, and experienced stock price decline of 6.49% following the announcement.

Keywords

#securities fraud investigation #class action lawsuit #impairment charges #financial guidance reduction #net loss #stock price decline

Tickers

WALD WALDW

← Prev: INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Caledonia Mining Corporation Plc - CMCL

Next: INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Home Depot, Inc. - HD →